Viewing Study NCT04836351



Ignite Creation Date: 2024-05-06 @ 4:00 PM
Last Modification Date: 2024-10-26 @ 2:01 PM
Study NCT ID: NCT04836351
Status: UNKNOWN
Last Update Posted: 2021-04-08
First Post: 2021-03-29

Brief Title: Rehabilitation for Patients With Persistent Symptoms Post COVID-19
Sponsor: Western Norway University of Applied Sciences
Organization: Western Norway University of Applied Sciences

Study Overview

Official Title: Feasibility Usefulness and Evaluation of a Concentrated Rehabilitation for Patients With Persistent Symptoms Post COVID-19
Status: UNKNOWN
Status Verified Date: 2021-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A large proportion of persons who have had COVID-19 have reported persisted symptoms as fatigue and dyspnea months post infection which affect activities of daily living

The aim of the study is to examine the feasibility and safety of a concentrated rehabilitation program with a mobile application follow-up for persons with persistent symptoms post COVID-19 infection We will examine recruitment availability adherence to the program goal achievement and resources requirements

Methods A feasibility study with one group pre-post test design with 10-20 persons between 18-67 years with persistent symptoms post COVID-19 will be included The intervention is 3 1-2 days concentrated rehabilitation with a mobile application follow-up for 3 months

Following assessments wil be used Cardiopulmonary exercise testing lung function functional performance tests questionnaires regarding dyspnea fatigue anxiety depression work-status health status sleep behavior physical activity level

Demographic data before and after the intervention will be presented Focus group interview will be done with the participants The interview will be analysed using systematic text condensation
Detailed Description: In March 2020 the World Health Organization WHO declared the COVID-19 outbreak to be a pandemic and a year later more than 120 000 000 people are confirmed with the disease The disease has caused more than 2 700 000 deaths globally Norway has a low mortality rate compared to rest of the world However a large proportion 10-33 of the patients worldwide have reported persistent symptoms such as dyspnea reduced exercise capacity loss of tastesmell and fatigue months after the infection Persistent symptoms are also found in younger populations and in persons with an initially mild disease

The intervention will take place at Helse i Hardanger HiHHealth center in Hardanger Norway The participants will stay for a 3 -day rehabilitation intervention if needed another 1 or 2-day stay will be offered about a month later The concentrated treatment will be given by an interdisciplinary team including doctors physiotherapists nutritionists pharmacists psychologistspsychiatrists and nurses The intervention is an individualized group treatment based on behavioural change

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None